Large-Scale Study of Mutations That Drive Squamous Cell Lung Cancer
After mapping genetic changes in tumors from nearly 200 patients, researchers from The Cancer Genome Atlas (TCGA) initiative have identified possible drug targets in squamous cell lung cancer, the second most common form of lung cancer.
• | NCI press release: TCGA maps squamous cell lung cancer |
• | About The Cancer Genome Atlas (TCGA) |
• | NCI's lung cancer home page |
Cancer Research News
- UNC scientists unearth cell death mystery that yields new suspect for cancer drug development
- Brigham and Women's Hospital researchers find that missing pieces of DNA structure are a red flag for deadly skin cancer
- Washington University School of Medicine researchers find that in lung cancer, smokers have 10 times more genetic damage than never-smokers
Visit the NCI News Center